**Core Concept**
Preoperative reduction of thyroid gland size and vascularity is crucial to facilitate a safe thyroidectomy. This process is known as thyroid lobectomy or thyroidectomy prep, and it helps in minimizing the risk of bleeding and reducing the size of the gland, thereby making it easier to remove.

**Why the Correct Answer is Right**
The reduction of thyroid gland size and vascularity is achieved through the administration of a medication called **Thyroid Hormone Withdrawal**. This involves withdrawing the patient's thyroid hormone replacement therapy (T4) for a period of time, usually 2-6 weeks, prior to surgery. The thyroid gland then undergoes a process called **atrophy**, where the cells shrink due to the absence of thyroid hormone. This reduction in size and vascularity makes the gland easier to remove during surgery. Additionally, the withdrawal of thyroid hormone also helps in reducing the vascularity of the gland, thereby minimizing the risk of bleeding.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the process of reducing thyroid gland size and vascularity prior to thyroidectomy.
**Option B:** This option is incorrect because it is not a recognized method for reducing thyroid gland size and vascularity prior to thyroidectomy.
**Option C:** This option is incorrect because it is a different procedure altogether and not related to preoperative reduction of thyroid gland size and vascularity.

**Clinical Pearl / High-Yield Fact**
It is essential to note that thyroid hormone withdrawal should be done under close supervision, as hypothyroidism can occur if the patient is not carefully managed. A preoperative consultation with an endocrinologist or a surgeon with expertise in thyroid surgery is recommended to discuss the optimal timing and management of thyroid hormone withdrawal.

**Correct Answer:** C. Thyroid hormone withdrawal